Dextromethorphan Hbr/Quinidine
Brand name: Nuedexta
Rank #222 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$60.7M
Total Cost
60,863
Total Claims
$60.7M
Total Cost
2,132
Prescribers
$997
Cost per Claim
984
Beneficiaries
62,350
30-Day Fills
$28K
Avg Cost/Provider
29
Avg Claims/Provider
Share of Medicare Part D Spending
0.02%
of total Medicare Part D spending
$60.7M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $60.7M total
🔎 Data Overview
Average cost of $61,663 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Dextromethorphan Hbr/Quinidine
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Robert Morton | Psychiatry | Ada, OK | 544 | $646K |
| 2 | Lisa Sweeney | Nurse Practitioner | West Melbourne, FL | 414 | $612K |
| 3 | Amaiak Chilingaryan | Neurology | Glendale, CA | 278 | $462K |
| 4 | Parikshit Deshmukh | Psychiatry | Oxford, FL | 306 | $429K |
| 5 | Maryrita Mallet | Psychiatry | Weatherford, TX | 238 | $386K |
| 6 | Dmitriy Grinshpun | Neurology | Brooklyn, NY | 164 | $306K |
| 7 | Dolores Stefanski | Nurse Practitioner | Tampa, FL | 191 | $262K |
| 8 | Marina Neystat | Neurology | Forest Hills, NY | 153 | $257K |
| 9 | Alexander Frank | Family Practice | Oklahoma City, OK | 312 | $246K |
| 10 | Jyh-Haur Lu | Neurology | Flushing, NY | 137 | $245K |
| 11 | Cynthia Marengo | Nurse Practitioner | Inverness, FL | 169 | $244K |
| 12 | Srinath Tadakamalla | Family Practice | Harrisonville, MO | 304 | $234K |
| 13 | Vadim Baram | Psychiatry | Saint Louis, MO | 149 | $211K |
| 14 | Julia Yasek | Nurse Practitioner | New York, NY | 93 | $200K |
| 15 | Scott Brehaut | Family Practice | Clinton, NY | 109 | $188K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 219 | Furosemide (Furosemide) | $62.3M | 9,788,207 |
| 220 | Buprenorphine (Buprenorphine) | $61.1M | 156,598 |
| 221 | Ferric Citrate (Auryxia) | $60.7M | 32,798 |
| 222 | Dextromethorphan Hbr/Quinidine (Nuedexta) | $60.7M | 60,863 |
| 223 | Interferon Beta-1a/Albumin (Rebif) | $60.7M | 5,917 |
| 224 | Sodium Zirconium Cyclosilicate (Lokelma) | $60.2M | 77,902 |
| 225 | Golimumab (Simponi Aria) | $59.9M | 8,718 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology